Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders. - Maciuba S; Bowden GD; Stratton HJ; Wisniewski K; Schteingart CD; Almagro JC; Valadon P; Lowitz J; Glaser SM; Lee G; Dolatyari M; Navratilova E; et al. (MAbs, 2023)